ArticleHeliyon2023
Healthcare As a Service (HAAS): CNN-based cloud computing model for ubiquitous access to lung cancer diagnosis.
Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- A deep learning model to enhance lung cancer detection using 'Dual-Branch' model classification approach.PloS one · 2026Article
- Artificial Intelligence Advancements in Oncology: A Review of Current Trends and Future Directions.Biomedicines · 2025Review
- A two stage blood cell detection and classification algorithm based on improved YOLOv7 and EfficientNetv2.Scientific reports · 2025Article
- Edge-Cloud Synergy for AI-Enhanced Sensor Network Data: A Real-Time Predictive Maintenance Framework.Sensors (Basel, Switzerland) · 2024Article
- A Novel IDS with a Dynamic Access Control Algorithm to Detect and Defend Intrusion at IoT Nodes.Sensors (Basel, Switzerland) · 2024Article
- Prediction of Tuberculosis From Lung Tissue Images of Diversity Outbred Mice Using Jump Knowledge Based Cell Graph Neural Network.IEEE access : practical innovations, open solutions · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The field of automated lung cancer diagnosis using Computed Tomography (CT) scans has been significantly advanced by the precise predictions offered by Convolutional Neural Network (CNN)-based classifiers. Critical areas of study include improving image quality, optimizing learning algorithms, and enhancing diagnostic accuracy. To facilitate a seamless transition from research laboratories to real-world applications, it is crucial to improve the technology's usability-a factor often neglected in current state-of-the-art research. Yet, current state-of-the-art research in this field frequently overlooks the need for expediting this process. This paper introduces Healthcare-As-A-Service (HAAS), an innovative concept inspired by Software-As-A-Service (SAAS) within the cloud computing paradigm. As a comprehensive lung cancer diagnosis service system, HAAS has the potential to reduce lung cancer mortality rates by providing early diagnosis opportunities to everyone. We present HAASNet, a cloud-compatible CNN that boasts an accuracy rate of 96.07%. By integrating HAASNet predictions with physio-symptomatic data from the Internet of Medical Things (IoMT), the proposed HAAS model generates accurate and reliable lung cancer diagnosis reports. Leveraging IoMT and cloud technology, the proposed service is globally accessible via the Internet, transcending geographic boundaries. This groundbreaking lung cancer diagnosis service achieves average precision, recall, and F1-scores of 96.47%, 95.39%, and 94.81%, respectively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.